Phase II clinical trial of hypofractionated radiotherapy using proton beams for prostate cancer
Phase 2
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000010510
- Lead Sponsor
- Proton Medical Research Center, University of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 102
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who 1) have lymph node metastasis 2) have distant metastasis 3) severe comcomitant diseases such as active infection, heart failure and myocardial infarction, severe respiratory dysfunction, renal faiure, and uncotrolled diabetes mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5-year rate of Grade 2 or worse late toxicity
- Secondary Outcome Measures
Name Time Method Acute and late toxicity rate, biochemical relapse-free rate, overall survival rate, cause-specific survival rate, and clinical relapse-free survival rate